These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Myer L, Denny L, Wright TC, Kuhn L. Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547 [Abstract] [Full Text] [Related]
4. Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception. Overton ET, Shacham E, Singhatiraj E, Nurutdinova D. Contraception; 2008 Aug; 78(2):125-30. PubMed ID: 18672113 [Abstract] [Full Text] [Related]
5. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [Abstract] [Full Text] [Related]
17. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women. Kiweewa FM, Brown E, Mishra A, Nair G, Palanee-Phillips T, Mgodi N, Nakabiito C, Chakhtoura N, Hillier SL, Baeten JM, MTN-020/ASPIRE Study Team. J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632 [Abstract] [Full Text] [Related]
19. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant. Deese J, Philip N, Lind M, Ahmed K, Batting J, Beksinska M, Edward VA, Louw CE, Onono M, Palanee-Phillips T, Smit JA, Baeten JM, Donnell D, Mastro TD, Mugo NR, Nanda K, Rees H, Morrison C. Sex Transm Infect; 2021 Jun; 97(4):249-255. PubMed ID: 33208512 [Abstract] [Full Text] [Related]
20. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies. Jain AK. Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]